Woodline Partners’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Woodline Partners’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,729	Closed	-$51K	–	854
2021 Q4	$51K	Hold	1,729	–	–	﹤0.01%	630
2021 Q3	$89K	Hold	1,729	–	–	﹤0.01%	588
2021 Q2	$211K	Hold	1,729	–	–	﹤0.01%	489
2021 Q1	$319K	Hold	1,729	–	–	0.01%	402
2020 Q4	$474K	Sell	1,729 -12,032	-87%	-$3.02M	0.01%	214
2020 Q3	$3.22M	Buy	+13,761	New	+$3.45M	0.11%	150

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Woodline Partners's FRLN Position: Q1 2022 in Review

Woodline Partners sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2022, closing a stake of 1,729 shares — an estimated $51K sold.

Woodline Partners first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $3.22M in Q3 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

Woodline Partners reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Woodline Partners sold 1,729 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2022, an estimated $51K.
Woodline Partners first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 6 quarters.
Woodline Partners's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $3.22M in Q3 2020.
19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2022.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.